* Celularity Inc CELU.OQ CELU.O is expected to report
results on November 15 (estimated).
* The New York City, New York-based company is expected to
report revenue of $1.73 million, according to the mean estimate
from 2 analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Celularity Inc is for a
loss of 34 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Celularity Inc
is $13, about 44.3% above its last closing price of $7.24.
This summary was machine generated November 12 at 12:41 GMT.
All figures in US dollars unless otherwise stated